Pneumocystis carinii pneumonia following a second infusion of infliximab
Open Access
- 1 August 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 41 (8) , 951-952
- https://doi.org/10.1093/rheumatology/41.8.951
Abstract
Sir, Anti‐tumour necrosis factor α (TNF‐α) blockade is increasingly used for severe rheumatoid arthritis (RA). There is an increased risk of infection, including atypical infection [1] associated with TNF‐α blockade. We report the development of Pneumocystis carinii pneumonia (PCP) in a man with RA shortly after commencing therapy with the anti‐TNF‐α agent infliximab (Remicade). This occurred in the setting of concomitant therapy with low‐dose weekly methotrexate and corticosteroids.Keywords
This publication has 0 references indexed in Scilit: